Abstract: An oral care composition containing at least 4% fatty amphiphile and from about 0.4% to about 5%, by weight of the composition, total flavor components. The flavor components contain at least 14%, by weight of the flavor components, of one or more high displaying flavor components.
Type:
Grant
Filed:
March 31, 2017
Date of Patent:
February 23, 2021
Assignee:
The Procter & Gamble Company
Inventors:
Steven Hamilton Hoke, Sanjeev Midha, Lawrence Edward Dolan, Michael Jude Leblanc, Karen Lehnhoff, Pierig Jean-Marie Lepont, Jianjun Justin Li, Laura H. Lucas
Abstract: A bone bioactive composition and kits comprising the composition, means for applying it and/or a metal implant are provided. The bone bioactive composition comprises a water-based salt solution comprising sodium dihydrogen phosphate and sodium chloride, and may also comprise additional elements. The composition and the kits are useful for promoting osteogenesis, particularly when a metal implant is used but also in case of periodontal diseases.
Type:
Grant
Filed:
October 26, 2017
Date of Patent:
February 23, 2021
Assignee:
BIOINTELLIGENCE SYSTEMS S.L.
Inventors:
Maher Al Atari Abouasi, José Luis Calvo Guirado
Abstract: The present disclosure is directed to a method for reducing bacteria in a precipitated calcium carbonate (CaCO3) slurry, the method including: adding water to calcium oxide (CaO) to form Ca(OH)2; treating the Ca(OH)2 with CO2 gas to form a slurry including precipitated CaCO3; neutralizing the slurry; and exposing the slurry that was neutralized to ozone in an amount sufficient to reduce bacteria in the precipitated calcium carbonate slurry. Oral care compositions including the precipitated calcium carbonate of the disclosed process are also described.
Abstract: The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of asenapine comprising a self-adhesive layer structure containing a therapeutically effective amount of asenapine, such asenapine TTS for use in a method of treatment, processes of manufacture of such TTS as well as asenapine and transdermal therapeutic systems containing asenapine for use in a method of treatment and to a method of treating a human patient by transdermal administration of asenapine.
Type:
Grant
Filed:
February 11, 2020
Date of Patent:
January 26, 2021
Assignee:
LTS LOHMANN THERAPIE-SYSTEME AG
Inventors:
Patrick Mohr, René Rietscher, René Eifler, Olga Bourquain
Abstract: A multifunctional dental composition may include polyoxyethylene sorbitan monooleate; sorbitan monooleate; benzoate sodium; distilled water; and ethylene diamine tetra acetic acid. For dental use, the required hydrophilic/lipophilic balance of the composition may be 7; and a critical micellar concentration of the composition may be 0.5%. The dental composition may be applied in a manner similar to how tap water is conventionally used, and the composition may be delivered to the dental unit system using various methods.
Abstract: A gel formulation has been developed which provides high loading, e.g., between about 5% and about 50% wt/wt agent/total gel weight, of a wide range of agents, especially amine-containing compounds such as local anesthetic agents that are known to be difficult to encapsulate, and which adhere to charged surfaces. Examples of pharmaceutically important amines include anesthetics, such as lidocaine. Tuning the ionic strength of an aqueous medium during preparation, suspension, and dialysis purification of the hydrogel composition allows for retention and/or control of agent loading contents, as well as a high capacity for adhesion to charged surfaces mimicking inflamed tissue. In some instances, the rheological properties of the gel can be tuned such as to impart thixotropic properties to the gels formed.
Type:
Grant
Filed:
May 8, 2018
Date of Patent:
January 5, 2021
Assignee:
ALIVIO THERAPEUTICS, INC.
Inventors:
Derek G. van der Poll, Dominick J. Blasioli, Gregory T. Zugates
Abstract: There is provided a solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form includes at least one biologically active material, and at least one matrix forming agent, wherein the dosage form substantially dissolves in the oral cavity. A method of producing the same and a kit including the same are also provided.
Type:
Grant
Filed:
June 27, 2018
Date of Patent:
December 8, 2020
Assignee:
iX Biopharma Ltd.
Inventors:
Chin Beng Stephen Lim, Vivian Bruce Sunderland, Yip Hang Eddy Lee
Abstract: A composition for mixing with water for use as an oral rinse, comprising monobasic sodium phosphate, dibasic sodium phosphate, sodium chloride, and calcium chloride.
Abstract: The present invention relates to a three-dimensional molding type powder makeup cosmetic composition, wherein the powder makeup cosmetic composition has a soft feeling of use and excellent adhesion and sustain power and mitigates the generation of creases by containing a powder phase in an oil gel phase and the powder makeup cosmetic composition can be molded into various three-dimensional designs due to physical characteristics of the oil gel phase.
Abstract: A submicron structure comprising a silica body defining a plurality of pores that are suitable to receive molecules therein, and having a surface, and a phospholipid bilayer coating the surface, wherein said submicron structure has a maximum dimension of less than one micron, and wherein the phospholipid bilayer stably seals the plurality of pores; and wherein the submicron structure is a member of a monodisperse population of submicron structures.
Type:
Grant
Filed:
March 5, 2014
Date of Patent:
November 10, 2020
Assignee:
The Regents of the University of California
Inventors:
Andre E. Nel, Jeffrey I. Zink, Huan Meng
Abstract: The present invention provides rechargeable dental materials that can be widely applied in a variety of dental applications. The rechargeable dental materials of the invention may be included in dental primers, dental adhesives, dental resins, dental composites, dental bonding systems and the like, as well as dental cements, dental sealants, dental bases and dental liners, each of which is rechargeable with calcium and phosphate ions. The present invention also provides for a method of recharging the rechargeable dental material with calcium and phosphate ions.
Abstract: Medical devices comprise a polymeric body comprising: a base polymeric formulation comprising at least a polymer or co-polymer of propylene; and an additive comprising a copolymer having a polypropylene backbone and hybrid micromolecule side-chains based on organo-functional silanes (PP-g-XSiOA) in the presence of a co-agent, for example, difunctional metallic diacrylate monomers, where “X” is an organic group or an organo-functional group, and “A” is a metal, an inorganic oxide, an inorganic hydroxide, or any other inorganic material. X may be derived from a compound selected from the group consisting of epoxy, amino, acrylate, methacryloxy, and vinyl; and A is selected from the group consisting of: silicon, (Si), aluminum (Al), iron (Fe), titanium (Ti), silver (Ag), zinc (Zn), nickel (Ni), calcium (Ca), copper (Cu), tin (Sn); oxides thereof; hydroxides thereof; and mixtures of the foregoing. Antimicrobial agents are included in the polymeric body. The medical devices have enhanced antimicrobial properties.
Abstract: Disclosed is an implanted device, comprising a device base body and an active drug, wherein the device base body is pure zinc and/or a zinc alloy, the zinc content in the device base body is 0.1-100%, and the active drug comprises anti-allergic drugs. After the implantation of the implanted device into the human body, the surrounding tissues of the implant would not have a clear hypersensitive reaction due to the presence of the anti-allergic drugs, and the implanted device can be used to be implanted into the body for supporting organ chambers, to fill the hollow chambers of the organs and tissues or as orthopaedic implants etc.
Type:
Grant
Filed:
June 27, 2016
Date of Patent:
October 13, 2020
Assignee:
Lifetech Scientific (Shenzhen) Co. Ltd.
Inventors:
Deyuan Zhang, Liping Chen, Haiping Qi, Hongtao Sun, Jun Hu, Wenjiao Lin
Abstract: An aqueous surfactant composition comprising one or more alpha-sulfo fatty acid disalts (A) of the general formula (I), R1CH(SO3M1)COOM2??(I), wherein the radical R1 is a linear or branched alkyl or alkenyl radical with 6 to 18 carbon atoms and the radicals M1 and M2, independently of one another, are selected from the group H, Li, Na, K, Ca/2, Mg/2, ammonium, and alkanolamine, one or more amidoalkylbetaines (B) of the general formula (II), R2—CO—NH—(CH2)y—N+(CH3)2—CH2—COO???(II) in which the radical R2 is a linear or branched alkyl or alkenyl radical with 7 to 19 carbon atoms and the index y is an integer in the range 2 to 4, and water, where specific limiting conditions are to be observed. The compositions are transparent, storage-stable, characterized by good foaming ability and good viscosity, and are suitable for cosmetic products and also detergents and cleaners.
Abstract: An oral care composition containing a gel phase, potassium nitrate, a peroxide source, an abrasive, and a fluoride source. Phase separation is not visually perceptible in the oral care composition.
Abstract: An oral care composition containing a gel phase, potassium nitrate, an abrasive, and a fluoride source. The gel network phase contains a cold dispersible fatty amphiphile and phase separation is not visually perceptible in the oral care composition.
Abstract: There is provided a fast dissolving solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form comprises at least one biologically active material, and at least one matrix forming agent, wherein the dosage form substantially dissolves in the oral cavity. A method of producing the same and a kit comprising the same are also provided.
Type:
Grant
Filed:
October 26, 2010
Date of Patent:
August 18, 2020
Assignee:
iX Biopharma Ltd.
Inventors:
Chin Beng Stephen Lim, Vivian Bruce Sunderland, Yip Hang Eddy Lee
Abstract: An aqueous, intra-oral, transparent nanoemulsion blend in the form of a stable dispersion is provided that delivers both oil- and water-soluble components of a vitamin supplement in the desired concentrations to the cells of a mammal when orally administered. The transparent nanoemulsion blend includes at least two different bilayer water-core liposome components and at least one monolayer surfactant bound particle component. The transparent nanoemulsion blend optionally may include a micelle formed from phosphatidylcholine (PC).